Holen Sie sich die Stockscreener-App
1.03
0.92%
-0.0197
Schlusskurs vom Vortag:
$1.0497
Offen:
$1.04
24-Stunden-Volumen:
8,408
Relative Volume:
0.46
Marktkapitalisierung:
$12.04M
Einnahmen:
$996.00K
Nettoeinkommen (Verlust:
$-6.09M
KGV:
-1.9434
EPS:
-0.53
Netto-Cashflow:
$-9.76M
1W Leistung:
-3.70%
1M Leistung:
-6.27%
6M Leistung:
+0.97%
1J Leistung:
-31.58%
1-Tages-Spanne:
$1.03
$1.04
1-Wochen-Bereich:
$1.03
$1.09
52-Wochen-Spanne:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Firmenname
Therapeuticsmd Inc
Sektor
Telefon
561-961-1900
Adresse
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Vergleichen Sie TXMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.04 | 12.15M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
143.46 | 63.05B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.80 | 43.33B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.19 | 40.43B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.12 | 22.97B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
433.70 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-08-07 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-05-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-12-02 | Eingeleitet | Guggenheim | Buy |
| 2019-10-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-04-30 | Fortgesetzt | Noble Capital Markets | Outperform |
| 2018-06-15 | Eingeleitet | JP Morgan | Overweight |
| 2017-09-08 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2017-07-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2017-05-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2016-11-22 | Fortgesetzt | Jefferies | Buy |
| 2016-11-22 | Eingeleitet | Oppenheimer | Outperform |
| 2016-11-07 | Fortgesetzt | Guggenheim | Buy |
| 2016-04-04 | Eingeleitet | Goldman | Buy |
| 2015-12-08 | Bestätigt | Jefferies | Buy |
| 2015-12-08 | Bestätigt | Stifel | Buy |
| 2015-09-21 | Bestätigt | Jefferies | Buy |
| 2015-06-09 | Eingeleitet | Guggenheim | Buy |
| 2014-07-08 | Eingeleitet | FBR Capital | Outperform |
| 2014-04-17 | Bestätigt | Noble Financial | Buy |
| 2014-01-28 | Bestätigt | Noble Financial | Buy |
Alle ansehen
Therapeuticsmd Inc Aktie (TXMD) Neueste Nachrichten
Using R and stats models for TherapeuticsMD Inc. forecastingJuly 2025 Setups & Accurate Trade Setup Notifications - newser.com
Why TherapeuticsMD Inc. stock remains a top recommendationJuly 2025 Levels & Low Risk Entry Point Guides - newser.com
How to read the order book for TherapeuticsMD Inc.Buy Signal & Free Daily Entry Point Trade Alerts - newser.com
Can TherapeuticsMD Inc. stock surprise with earnings upsideJuly 2025 Outlook & Daily Volume Surge Signals - newser.com
How to forecast TherapeuticsMD Inc. trends using time seriesJuly 2025 Momentum & Accurate Trade Setup Notifications - newser.com
Will TherapeuticsMD Inc. price bounce be sustainableMarket Activity Report & Weekly Breakout Stock Alerts - newser.com
Can a trend reversal in TherapeuticsMD Inc. lead to recoveryJuly 2025 Breakouts & Fast Entry Momentum Alerts - newser.com
TherapeuticsMD Inc. stock prediction for this weekJuly 2025 Highlights & Reliable Breakout Forecasts - newser.com
TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Real time scanner hits for TherapeuticsMD Inc. explainedRisk Management & Free Community Consensus Stock Picks - newser.com
Will TherapeuticsMD Inc. stock go up soonJuly 2025 Short Interest & AI Enhanced Trade Execution Alerts - newser.com
How TherapeuticsMD Inc. (29TA) stock reacts to weak economyJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com
Can TherapeuticsMD Inc. (29TA) stock ride next bull market cycleEarnings Risk Summary & Weekly High Conviction Trade Ideas - newser.com
Is TherapeuticsMD Inc. stock attractive for hedge fundsJuly 2025 Spike Watch & High Yield Stock Recommendations - newser.com
TherapeuticsMD, Inc. (NASDAQ:TXMD) Short Interest Up 93.5% in September - Defense World
What analysts say about TherapeuticsMD Inc stockTrendline Breakouts & Minimal Capital Investment - earlytimes.in
Is TherapeuticsMD Inc. (29TA) stock a good hedge against inflationExit Point & Smart Investment Allocation Insights - newser.com
Published on: 2025-10-05 04:45:14 - newser.com
Forecasting TherapeuticsMD Inc. price range with options dataWeekly Stock Recap & High Yield Equity Trading Tips - newser.com
Real time pattern detection on TherapeuticsMD Inc. stockFed Meeting & Real-Time Volume Analysis Alerts - newser.com
TherapeuticsMD Inc 29TA Stock Analysis and ForecastBearish Engulfing Patterns & Small Investment Growth Plans - earlytimes.in
TherapeuticsMD Inc Stock Analysis and ForecastTrade Execution Strategies & Rapid Capital Appreciation - earlytimes.in
What analysts say about TherapeuticsMD Inc 29TA stockMarket Volatility Update & Interactive Charts for Smarter Trading - earlytimes.in
What drives TherapeuticsMD Inc stock priceRisk Adjusted Returns & Small Budget Wealth Building - earlytimes.in
Is TherapeuticsMD Inc a good long term investmentDividend Yield Trends & Free Expert Guidance For Growth - Early Times
Intraday pattern recognizer results for TherapeuticsMD Inc.2025 Performance Recap & Reliable Volume Spike Trade Alerts - newser.com
Finanzdaten der Therapeuticsmd Inc-Aktie (TXMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Therapeuticsmd Inc-Aktie (TXMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
| Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
| Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
| Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
| Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
1.02%
2.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):